Visit-to-visit blood pressure variation is associated with outcomes in a U-shaped fashion in patients with myocardial infarction complicated with systolic dysfunction and/or heart failure: findings from the EPHESUS and OPTIMAAL trials
暂无分享,去创建一个
K. Dickstein | J. McMurray | B. Pitt | F. Zannad | P. Rossignol | K. Duarte | J. Ferreira
[1] Claes Held,et al. Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial , 2017, European heart journal.
[2] Richard J McManus,et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis , 2016, British Medical Journal.
[3] A. D. de Craen,et al. Visit-to-visit blood pressure variability and future functional decline in old age , 2016, Journal of hypertension.
[4] B. Davis,et al. The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. , 2016, Hypertension.
[5] G. Mancia. Visit-to-Visit Blood Pressure Variability: An Insight Into the Mechanisms. , 2016, Hypertension.
[6] K. Swedberg,et al. Effect of Visit‐to‐Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the I f Inhibitor Ivabradine Trial (SHIFT) Trial , 2016, Journal of the American Heart Association.
[7] D. Atar,et al. Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High‐Risk Myocardial Infarction Database Initiative , 2015, European journal of heart failure.
[8] F. Zannad,et al. Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: Insights from the HEAAL study. , 2015, International journal of cardiology.
[9] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[10] F. Zannad,et al. Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases , 2013, Current opinion in nephrology and hypertension.
[11] F. Zannad,et al. Visit-to-Visit Blood Pressure Variability Is a Strong Predictor of Cardiovascular Events in Hemodialysis: Insights From FOSIDIAL , 2012, Hypertension.
[12] M. Hsieh,et al. Visit‐to‐visit variability in blood pressure strongly predicts all‐cause mortality in patients with type 2 diabetes: a 5·5‐year prospective analysis , 2012, European journal of clinical investigation.
[13] S. Oparil,et al. Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care , 2011, Journal of hypertension.
[14] S. Yusuf,et al. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND , 2010, Clinical Research in Cardiology.
[15] P. Rothwell,et al. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis , 2010, The Lancet.
[16] E. O’Brien,et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension , 2010, The Lancet.
[17] P. Rothwell,et al. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension , 2010, The Lancet.
[18] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[19] Philippe Lacroix,et al. Heart rate and pulse pressure at rest are major prognostic markers of early postoperative complications after coronary bypass surgery. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[20] Hans L Hillege,et al. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. , 2005, European heart journal.
[21] A. Burger,et al. Relation between pulse pressure and survival in patients with decompensated heart failure. , 2004, The American journal of cardiology.
[22] B. Pitt,et al. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .
[23] Sunil J Rao,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .
[24] K. Dickstein,et al. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial , 2002, The Lancet.
[25] K. Dickstein,et al. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan. , 1999, The American journal of cardiology.
[26] P. Whelton,et al. Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial) , 2017, Hypertension.
[27] Volkmar Falk,et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.
[28] J. López-Sendón,et al. The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction , 2004, Cardiovascular Drugs and Therapy.